Driving research of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS),
Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia and Post COVID .

Exciting News: Harvard Collaborative Projects Advancing

#TripleTuesdayOMFCA Spotlight – Harvard Collaboration

Every donation today through December 3 will be tripled!

The OMF funded Harvard ME/CFS Collaboration, led by Ronald G. Tompkins, MD, ScD, and Wenzhong Xiao, PhD, is a partnership of leading scientists, doctors, and researchers from Harvard-affiliated hospitals including Massachusetts General Hospital (MGH) and collaborators from Sweden and the United Kingdom who share a commitment to advancing research and developing effective therapies for this complex chronic disease.

Dr. Tompkins said, “I have had a 43 year career at MGH as a doctor and scientist with tremendous experience in inflammation and metabolism. I am now focusing on medical science to find insights and treatments for ME/CFS.

These initiatives stand to impact millions whose lives have been overturned by ME/CFS.

Your donation to Triple Giving Tuesday OMFCA support the critical advances of the Harvard Collaboration.

The Collaboration seeks to conduct “basic science” research — with emphasis on uncovering the mechanisms behind the most debilitating symptoms of ME/CFS — as well as clinical studies to identify new forms of treatment.

Make a donation to Triple Giving Tuesday OMFCA today to accelerate research.

Donations made any day of the week today through International Giving Tuesday, December 3, 2019, are eligible to be TRIPLED. Triple your impact on research.

Learn more about the OMF funded Harvard Collaboration.